Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON

Abstract

Zhu–Tokita–Takenouchi–Kim (ZTTK) syndrome, an intellectual disability syndrome first described in 2016, is caused by heterozygous loss-of-function variants in SON. Its encoded protein promotes pre-mRNA splicing of many genes essential for development. Whereas individual phenotypic traits have previously been linked to erroneous splicing of SON target genes, the phenotypic spectrum and the pathogenicity of missense variants have not been further evaluated. We present the phenotypic abnormalities in 52 individuals, including 17 individuals who have not been reported before. In total, loss-of-function variants were detected in 49 individuals (de novo in 47, inheritance unknown in 2), and in 3, a missense variant was observed (2 de novo, 1 inheritance unknown). Phenotypic abnormalities, systematically collected and analyzed in Human Phenotype Ontology, were found in all organ systems. Significant inter-individual phenotypic variability was observed, even in individuals with the same recurrent variant (n = 13). SON haploinsufficiency was previously shown to lead to downregulation of downstream genes, contributing to specific phenotypic features. Similar functional analysis for one missense variant, however, suggests a different mechanism than for heterozygous loss-of-function. Although small in numbers and while pathogenicity of these variants is not certain, these data allow for speculation whether de novo missense variants cause ZTTK syndrome via another mechanism, or a separate overlapping syndrome. In conclusion, heterozygous loss-of-function variants in SON define a recognizable syndrome, ZTTK, associated with a broad, severe phenotypic spectrum, characterized by a large inter-individual variability. These observations provide essential information for affected individuals, parents, and healthcare professionals to ensure appropriate clinical management.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Schematic representation of variants in SON.
Fig. 2: Photos of individuals with a pathogenic variant in SON.
Fig. 3: Functional analysis of non-haploinsufficiency variants.

Similar content being viewed by others

Data availability

The data that support the findings of this study are available in the Supplementary material of this article and online at https://databases.lovd.nl/shared/genes/SON and https://humandiseasegenes.nl/son/.

References

  1. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367:1921–9.

    Article  Google Scholar 

  2. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, et al. A de novo paradigm for mental retardation. Nat Genet. 2010;42:1109–12.

    Article  CAS  Google Scholar 

  3. Vissers LE, Gilissen C, Veltman JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet. 2016;17:9–18.

    Article  CAS  Google Scholar 

  4. Zhu X, Petrovski S, Xie P, Ruzzo EK, Lu YF, McSweeney KM, et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med. 2015;17:774–81.

    Article  CAS  Google Scholar 

  5. Tokita MJ, Braxton AA, Shao Y, Lewis AM, Vincent M, Küry S, et al. De novo truncating variants in SON cause intellectual disability, congenital malformations, and failure to thrive. Am J Hum Genet. 2016;99:720–7.

    Article  CAS  Google Scholar 

  6. Kim JH, Shinde DN, Reijnders MRF, Hauser NS, Belmonte RL, Wilson GR, et al. De novo mutations in SON disrupt RNA splicing of genes essential for brain development and metabolism, causing an intellectual-disability syndrome. Am J Hum Genet. 2016;99:711–9.

    Article  CAS  Google Scholar 

  7. Takenouchi T, Miura K, Uehara T, Mizuno S, Kosaki K. Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: possible contribution to Braddock-Carey syndrome phenotype. Am J Med Genet A. 2016;170:2587–90.

    Article  CAS  Google Scholar 

  8. Hickey CJ, Kim JH, Ahn EY. New discoveries of old SON: a link between RNA splicing and cancer. J Cell Biochem. 2014;115:224–31.

    Article  CAS  Google Scholar 

  9. Ahn EY, DeKelver RC, Lo MC, Nguyen TA, Matsuura S, Boyapati A, et al. SON controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell. 2011;42:185–98.

    Article  CAS  Google Scholar 

  10. Sharma A, Markey M, Torres-Muñoz K, Varia S, Kadakia M, Bubulya A, et al. Son maintains accurate splicing for a subset of human pre-mRNAs. J Cell Sci. 2011;124:4286–98.

    Article  CAS  Google Scholar 

  11. Kim JH, Park EY, Chitayat D, Stachura DL, Schaper J, Lindstrom K, et al. SON haploinsufficiency causes impaired pre-mRNA splicing of CAKUT genes and heterogeneous renal phenotypes. Kidney Int. 2019;95:1494–504.

    Article  CAS  Google Scholar 

  12. Lu X, Göke J, Sachs F, Jacques P, Liang H, Feng B, et al. SON connects the splicing-regulatory network with pluripotency in human embryonic stem cells. Nat Cell Biol. 2013;15:1141–52.

    Article  CAS  Google Scholar 

  13. Ueda M, Matsuki T, Fukada M, Eda S, Toya A, Iio A, et al. Knockdown of Son, a mouse homologue of the ZTTK syndrome gene, causes neuronal migration defects and dendritic spine abnormalities. Mol Brain. 2020;13:80.

    Article  CAS  Google Scholar 

  14. Kim JH, Baddoo MC, Park EY, Stone JK, Park H, Butler TW, et al. SON and its alternatively spliced isoforms control MLL complex-mediated H3K4me3 and transcription of leukemia-associated genes. Mol Cell. 2016;61:859–73.

    Article  CAS  Google Scholar 

  15. Ahn EE, Higashi T, Yan M, Matsuura S, Hickey CJ, Lo MC, et al. SON protein regulates GATA-2 through transcriptional control of the microRNA 23a~27a~24-2 cluster. J Biol Chem. 2013;288:5381–8.

    Article  CAS  Google Scholar 

  16. Quintana Castanedo L, Sánchez Orta A, Maseda Pedrero R, Santos Simarro F, Palomares Bralo M, Feito Rodríguez M, et al. Skin and nails abnormalities in a patient with ZTTK syndrome and a de novo mutation in SON. Pediatr Dermatol. 2020;37:517–9.

  17. Tan Y, Duan L, Yang K, Liu Q, Wang J, Dong Z, et al. A novel frameshift variant in SON causes Zhu-Tokita-Takenouchi-Kim Syndrome. J Clin Lab Anal. 2020;34:e23326.

  18. Yang Y, Xu L, Yu Z, Huang H, Yang L. Clinical and genetic analysis of ZTTK syndrome caused by SON heterozygous mutation c.394C>T. Mol Genet Genom Med. 2019;7:e953.

    Google Scholar 

  19. Chiu C, Loth S, Kuhlen M, Ginzel S, Schaper J, Rosenbaum T, et al. Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots. Fam Cancer. 2019;18:353–8.

    Article  CAS  Google Scholar 

  20. Slezak R, Smigiel R, Rydzanicz M, Pollak A, Kosinska J, Stawinski P, et al. Phenotypic expansion in Zhu-Tokita-Takenouchi-Kim syndrome caused by de novo variants in the SON gene. Mol Genet Genom Med. 2020;8:e1432.

    CAS  Google Scholar 

  21. Robinson PN, Köhler S, Bauer S, Seelow D, Horn D, Mundlos S. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008;83:610–5.

    Article  CAS  Google Scholar 

  22. Dingemans AJM, Stremmelaar DE, Vissers L, Jansen S, Nabais Sá MJ, van Remortele A, et al. Human Disease Genes website series: an international, open and dynamic library for up-to-date clinical information. Am J Med Genet A. 2021;185:1039–46.

  23. Portal SJCsRHPD. ProteinPaint. 2015.

  24. van der Donk R, Jansen S, Schuurs-Hoeijmakers JHM, Koolen DA, Goltstein L, Hoischen A, et al. Next-generation phenotyping using computer vision algorithms in rare genomic neurodevelopmental disorders. Genet Med. 2019;21:1719–25.

    Article  Google Scholar 

  25. Dingemans AJM, Stremmelaar DE, van der Donk R, Vissers L, Koolen DA, Rump P, et al. Quantitative facial phenotyping for Koolen-de Vries and 22q11.2 deletion syndrome. Eur J Hum Genet. 2021. [epub ahead of print]

  26. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.

    Article  Google Scholar 

Download references

Acknowledgements

First and foremost, we are grateful to all individuals and their parents for participation in this study. Next to that, we are grateful to the Dutch Organisation for Health Research and Development: ZON-MW grants 912-12-109 (to BBAdV and LELMV), Donders Junior researcher grant 2019 (to BBAdV and LELMV) and Aspasia grant 015.014.066 (to LELMV). This study was also supported by the US National Institute of Health grants R01 CA190688 and R01 CA236911 (to E-YEA). This work has been generated through a collaboration with the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA) [EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516]. The aims of this study contribute to the Solve-RD project (to LELMV) that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779257.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: A.J.M.D, K.M.G.T, E.Y.E.A., B.B.A.d.V, L.E.L.M.V; Data collection: all authors; Data Analysis: A.J.M.D, K.M.G.T; Funding acquisition: L.E.L.M.V, B.B.A.d.V, E.Y.E.A.; Writing – original draft: A.J.M.D, K.M.G.T, E.Y.E.A., B.B.A.d.V, L.E.L.M.V; Writing – review and editing: all authors.

Corresponding authors

Correspondence to Bert B. A. de Vries or Lisenka E. L. M. Vissers.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

Consent for participation in this study was obtained via the individuals’ legal guardians, and the study was approved by the institutional review board of the Radboud University Medical Center (#2020–6763). For individuals whose facial photos are depicted in Fig. 2, additional informed signed consent was obtained for the publication of photographs.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dingemans, A.J.M., Truijen, K.M.G., Kim, JH. et al. Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON. Eur J Hum Genet 30, 271–281 (2022). https://doi.org/10.1038/s41431-021-00960-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41431-021-00960-4

This article is cited by

Search

Quick links